Literature DB >> 24782253

New hepatitis C therapies.

Jean-Michel Pawlotsky1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24782253     DOI： 10.1055/s-0034-1371178

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN： 0272-8087            Impact factor:   6.115


× No keyword cloud information.
  3 in total

1.  Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin.

Authors:  Sylvie Larrat; Sophie Vallet; Sandra David-Tchouda; Alban Caporossi; Jennifer Margier; Christophe Ramière; Caroline Scholtes; Stéphanie Haïm-Boukobza; Anne-Marie Roque-Afonso; Bernard Besse; Elisabeth André-Garnier; Sofiane Mohamed; Philippe Halfon; Adeline Pivert; Hélène LeGuillou-Guillemette; Florence Abravanel; Matthieu Guivarch; Vincent Mackiewicz; Olivier Lada; Thomas Mourez; Jean-Christophe Plantier; Yazid Baazia; Sophie Alain; Sebastien Hantz; Vincent Thibault; Catherine Gaudy-Graffin; Dorine Bouvet; Audrey Mirand; Cécile Henquell; Joel Gozlan; Gisèle Lagathu; Charlotte Pronier; Aurélie Velay; Evelyne Schvoerer; Pascale Trimoulet; Hervé Fleury; Magali Bouvier-Alias; Etienne Brochot; Gilles Duverlie; Sarah Maylin; Stéphanie Gouriou; Jean-Michel Pawlotsky; Patrice Morand
Journal:  J Clin Microbiol       Date:  2015-04-29       Impact factor: 5.948

Review 2.  Hepatitis C virus: Virology, diagnosis and treatment.

Authors:  Hui-Chun Li; Shih-Yen Lo
Journal:  World J Hepatol       Date:  2015-06-08

3.  An NS5A single optimized method to determine genotype, subtype and resistance profiles of Hepatitis C strains.

Authors:  Elisabeth Andre-Garnier; Bernard Besse; Audrey Rodallec; Olivier Ribeyrol; Virginie Ferre; Caroline Luco; Laura Le Guen; Nathalie Bourgeois; Jérôme Gournay; Eric Billaud; François Raffi; Marianne Coste-Burel; Berthe-Marie Imbert-Marcille
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.